![](https://investorshub.advfn.com/uicon/61569.png?cb=1621345219)
Tuesday, March 19, 2024 11:41:10 AM
“Findings of this study suggest that metformin may be useful as a therapeutic tool for protection against AMD development in patients without diabetes,” the researchers concluded.
“These findings provide further impetus to study metformin’s usefulness in protecting against AMD in prospective clinical trials.”
https://www.consultant360.com/exclusive/impact-metformin-use-age-related-macular-degeneration-among-patients-without-diabetes
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent CUBT News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/06/2024 09:31:41 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM